AINO Aino Health AB

Correction: Aino Health year-end report January-December 2024

Correction: Aino Health year-end report January-December 2024

Correction: The reason for the correction is that the previous mailing did not contain the attached report.

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.

Aino reveals the root causes for absence at work

October - December 2024

  • Net sales were KSEK 6 000 (6 313)
  • Profit/loss after financial items was KSEK -3 451 (-3 851)
  • Earnings per share were SEK -0,0 (-0,0)

January – December 2024

  • Net sales were KSEK 23 941 (23 918)
  • Profit/loss after financial items was KSEK -9 915 (-10 661)
  • Earnings per share were SEK-0,1 (-0,2) SEK

 

Stable demand and new customer partnerships

During the fourth quarter, we continued to grow through new business and deeper partnerships. We see a particularly positive development in the Finnish market, where our partnerships with both public and private organisations continue. During the quarter, three public sector organisations chose to implement our SaaS platform, which strengthens our position in the public sector.

Greater focus on global customers

We see a clear trend where more and more international companies want to scale up their efforts for work ability, employee health and social sustainability. During the quarter, we continued our efforts to broaden the use of our SaaS solution by our global customers, from local initiatives to multi-country and multi-business solutions. The positive impact of our services is also highlighted in customer testimonials from, for example, ArcelorMittal and Adecco Group, which are available on our website.

Further development of root cause analysis

During the quarter, we continued to develop our root cause analysis of sickness absence and work environment problems. These insights enable us to fine-tune our solutions and provide clients with a better strategic basis for decision-making to actively work on strengthening employee health and reducing sickness absence.

Financial situation

The number of users remained unchanged during the quarter, but we expect an increase in the first quarter of 2025. We expect the liquidity situation to improve, driven by the implementation of new contracts and continued demand. With more new customers, a more data-driven service and a clear expansion strategy, we see good opportunities to increase sales, strengthen cash flow and improve earnings during the year.We look forward to a continued productive year in which we broaden our customer relationships, further develop our SaaS and create clear business benefits for our customers.

 

For more information

Jyrki Eklund

CEO Aino Health

Phone: 1

 

Certified adviser

Carnegie Investment Bank AB (publ)

For more information see: 

 

About Aino Health (publ)

Aino Health is the leading provider of Software as a Service solutions in Corporate Health Management.

The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs and improves business outcomes through increased productivity and employee engagement by making health, well-being and safety an integral part of daily work. For more information visit ainohealth.com.

 

Link to the report

Attachment



EN
21/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aino Health AB

 PRESS RELEASE

Leading European Shipbuilder Selects Aino’s SaaS Platform

Leading European Shipbuilder Selects Aino’s SaaS Platform Aino Health AB (publ) has signed an agreement with one of Europe’s leading shipbuilding companies for the implementation of the Aino SaaS platform. The agreement covers 2,000 employees and aims to strengthen the customer’s proactive work ability management and employee well-being initiatives. “We are proud that our platform will support this organization in improving work ability and reducing health-related risks across their operations,” says Jyrki Eklund, CEO of Aino Health. Through the Aino platform, the customer will gain acces...

 PRESS RELEASE

Ledande europeisk skeppsvarv väljer Ainos SaaS-plattform

Ledande europeisk skeppsvarv väljer Ainos SaaS-plattform Aino Health AB (publ) har tecknat ett avtal med ett av Europas ledande skeppsvarv för implementering av Ainos SaaS-plattform. Avtalet omfattar 2 000 anställda och syftar till att stärka kundens proaktiva arbetsförmågearbete och initiativ för medarbetarhälsa. "Vi är stolta över att vår plattform kommer att stödja denna organisation i att förbättra arbetsförmågan och minska hälsorelaterade risker i hela verksamheten," säger Jyrki Eklund, VD för Aino Health. Genom Ainos plattform får kunden tillgång till realtidsdata, automatiserade pr...

 PRESS RELEASE

Kommuniké från årsstämma 2025 i Aino Health AB (publ)

Kommuniké från årsstämma 2025 i Aino Health AB (publ) Aino Health AB (publ), org.nr 559063–5073 (”Bolaget”), höll årsstämma tisdagen den 10 juni 2025 klockan 16.00 i Stockholm. I det följande redogörs för de viktigaste beslutens huvudsakliga innehåll. Fullständig information och handlingar kring stämmans beslut finns på Bolagets hemsida,  Årsstämman beslutade att fastställa framlagd resultaträkning och balansräkning, samt koncernresultaträkning och koncernbalansräkning.Årsstämman beslutade att disponera över Bolagets resultat enligt styrelsens förslag i årsredovisningen, innebärandes att i...

 PRESS RELEASE

Aino Health AB (publ): interim report january-march 2025

Aino Health AB (publ): interim report january-march 2025 This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail. Increased turnover. Positive cashflow. Positive EBITDA. January – March 2024 Turnover totalled 7 378 (5 994) TSEKProfit after financial items -554 (-2 943) TSEK Earnings per share -0,0 (-0,0) SEK The first quarter of 2025 has been characterised by a continued challenging market environment, shaped by cautious investment appetite and continued macroeconomic uncertainty. Despite these headwinds, I a...

 PRESS RELEASE

Aino Health AB (publ): Delårsrapport januari-mars 2025

Aino Health AB (publ): Delårsrapport januari-mars 2025 Ökad omsättning. Positivt kassaflöde. Positivt EBITDA. Januari - Mars 2025 Omsättningen uppgick till 7 378 (5 994) TSEKResultatet efter finansiella poster -554 (-2 943) TSEK Resultatet per aktie uppgick till -0,0 (-0,0) SEK Första kvartalet 2025 har präglats av en fortsatt utmanande marknadsmiljö, formad av försiktig investeringsvilja och fortsatt makroekonomisk osäkerhet. Trots dessa motvindar är jag glad att kunna rapportera konkreta framsteg i vårt arbete med att förbättra lönsamheten och bygga långsiktig motståndskraft för Aino. ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch